Hematopathology Fellowship

Fellows alternate covering the two major clinical service rotations focusing on diagnostic hematopathology. Immunophenotypic studies (Immunohistochemistry and Flow Cytometry) and other ancillary studies are incorporated as integral parts of both rotations.

• Bone marrow pathology, pediatrics and adult patients.
• Lymph node, peripheral blood and other body tissue/fluid diagnostic hematopathology, pediatrics and adult patients.

Each fellow has 8-10 weeks of elective/off-service time (including four weeks of vacation time) incorporated into the annual schedule of fellows' rotations. During these weeks, fellows are entirely free of all clinical service coverage/patient care responsibilities. This elective time can be used for various elective training activities, participation in a wide range of scholarly opportunities, and time to decompress and reduce pressure which is crucial to our fellows’ well-being.

Fellows participate in a variety of intra- and interdepartmental educational conferences held regularly.

• Hematopathology/cytogenetics rounds (weekly): Focus on cancer cytogenetics of hematopathology cases (conventional karyotype and FISH analysis), and discuss how cytogenetic findings can contribute to diagnosis, prognosis, and treatment.
• Molecular rounds (weekly): Focus on molecular studies of hematopathology cases (including targeted NGS studies, and B- and T-cell clonality studies, amongst others), and discuss how the molecular findings can contribute to diagnosis, prognosis, and treatment.
• Literature updates and reviews (weekly): Prepared and presented by fellows to improve rapid acquisition of current hematopathology knowledge.
• Hematology tumor boards: Organized by adult and pediatric hematology divisions, and held regularly to discuss neoplastic hematology cases with participation of multidisciplinary, inter-professional teams from different departments.

Fellows interested in research can take advantage of the extensive opportunities for translational investigations within the department or as collaborations with a host of groups conducting research throughout the medical center. An intermediate goal is a presentation at a national/international meeting, ideally leading to a publication in a peer-reviewed journal.

Applicants must have successfully completed training in combined anatomic and clinical pathology.

New York-Presbyterian Hospital/Columbia University Irving Medical Center will only accept J1 visas.

One year of ACGME Accredited training in Hematopathology.

All training is offered at one location: Department of Pathology and Cell Biology, Columbia University Irving Medical Center.

Two ACGME accredited positions are offered per academic year.

Our fellowship program participates in the hematopathology fellowship match program(link is external and opens in a new window), endorsed by the Society for Hematopathology and administered by NRMP.

An approximate timeline for July 2027 fellowship match applicants is as follows (exact dates may change):

• Summer/Fall 2025: Start accepting applications
• January 2026: Start interviewing
• February 4, 2026: Match opens for registration to programs and applicants
• March 11, 2026: Ranking opens
• April 1, 2026: Quota change and withdrawal deadline
• April 15, 2026: Ranking closes
• April 29, 2026: Match day
• July 2027: Start of fellowship 

Applications must include:

• Personal Statement
• Curriculum vitae
• Three letters of recommendation.

Completed applications (including recommendation letters) may be emailed directly to the program coordinator: pathhptraining@cumc.columbia.edu(link sends e-mail).

Will be commensurate with training level (PGY), as determined by New York-Presbyterian Hospital policy.

Craig Soderquist, MD
Program Director
Columbia University Irving Medical Center
Department of Pathology and Cell Biology
630 West 168th Street, VC14-237
New York, NY 10032
Email: crs2130@cumc.columbia.edu(link sends e-mail)

Marquis Fuse, MM
Manager, Education Programs
Department of Pathology and Cell Biology
Columbia University Irving Medical Center and New York Presbyterian Hospital
630 West 168th Street, PH 1587, New York, NY 10032
Tel: 212 305-9173 | Email: mlf2209@cumc.columbia.edu(link sends e-mail)

Ramonita Ferreira
Residency and Fellowship Program Coordinator
Department of Pathology and Cell Biology
Tel: 212-305-5697
Email: rf2739@cumc.columbia.edu(link sends e-mail)  cc: pathhptraining@cumc.columbia.edu(link sends e-mail)

• Craig Soderquist, MD
• George Vlad, PhD
• Murty Vundavalli, PhD
• Richard Oscar Francis, MD, PhD
• Vaidehi Jobanputra, PhD
• Amy Ku, MD, PhD